{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:13:24Z","timestamp":1790162004649,"version":"4.1.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,29]],"date-time":"2013-11-29T00:00:00Z","timestamp":1385683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0081171","type":"journal-article","created":{"date-parts":[[2013,11,29]],"date-time":"2013-11-29T21:13:36Z","timestamp":1385759616000},"page":"e81171","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Type-Specific Human Papillomavirus Biological Features: Validated Model-Based Estimates"],"prefix":"10.1371","volume":"8","author":[{"given":"Iacopo","family":"Baussano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Miriam","family":"Elfstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Lazzarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gillio-Tos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Carozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarosa","family":"Del Mistro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"D Forman","year":"2012","journal-title":"Vaccine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"C de Martel","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"JM Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer","volume":"131","author":"P Guan","year":"2012","journal-title":"Int J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"J Paavonen","year":"2009","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/597309","article-title":"The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 Years","volume":"199","author":"CM Wheeler","year":"2009","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(12)60919-2","article-title":"Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions","volume":"380","author":"I Soerjomataram","year":"2012","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/epirev\/mxj006","article-title":"Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease","volume":"28","author":"EJ Dasbach","year":"2006","journal-title":"Epidemiol Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1016\/j.vaccine.2008.04.053","article-title":"Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries","volume":"26","author":"SJ Goldie","year":"2008","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1473-3099(07)70083-X","article-title":"Cost-effectiveness analyses of human papillomavirus vaccination","volume":"7","author":"AT Newall","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1086\/425271","article-title":"Role of herd immunity in determining the effect of vaccines against sexually transmitted disease","volume":"191","author":"GP Garnett","year":"2005","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001648-200211000-00006","article-title":"The theoretical population-level impact of a prophylactic human papilloma virus vaccine","volume":"13","author":"JP Hughes","year":"2002","journal-title":"Epidemiology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3201\/eid1011.040222","article-title":"Evaluating human papillomavirus vaccination programs","volume":"10","author":"AV Taira","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"EH Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/aje\/kwp466","article-title":"Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus","volume":"171","author":"JA Bogaards","year":"2010","journal-title":"Am J Epidemiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1371\/journal.pmed.0030138","article-title":"Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses","volume":"3","author":"RV Barnabas","year":"2006","journal-title":"PLoS Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/aje\/kwm086","article-title":"Multiparameter calibration of a natural history model of cervical cancer","volume":"166","author":"JJ Kim","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/aje\/kwk059","article-title":"Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty","volume":"165","author":"N Van de Velde","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.vaccine.2010.11.082","article-title":"Modelling patterns of clearance of HPV-16 infection and vaccination efficacy","volume":"29","author":"I Baussano","year":"2011","journal-title":"Vaccine"},{"key":"ref20","article-title":"ndres-Beck B, Goldie SJ","author":"JJ Kim","year":"2007","journal-title":"The value of including boys in an HPV vaccination programme"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1016\/j.vaccine.2010.05.056","article-title":"Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis","volume":"28","author":"N Van de Velde","year":"2010","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e49614","DOI":"10.1371\/journal.pone.0049614","article-title":"Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approach","volume":"7","author":"HC Johnson","year":"2012","journal-title":"PLOS ONE"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1016\/j.vaccine.2008.07.041","article-title":"Seroepidemiology as basis for design of a human papillomavirus vaccination program","volume":"26","author":"J Ryding","year":"2008","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.epidem.2010.02.002","article-title":"HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions","volume":"2","author":"I Baussano","year":"2010","journal-title":"Epidemics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0266462310000085","article-title":"Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark","volume":"26","author":"J Olsen","year":"2010","journal-title":"Int J Technol Assess Health Care"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1016\/j.vaccine.2009.06.039","article-title":"Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria","volume":"27","author":"I Zechmeister","year":"2009","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"G Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1158\/1055-9965.EPI-12-1003","article-title":"High-throughput monitoring of human papillomavirus type distribution","volume":"22","author":"A S\u00f6derlund-Strand","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/eurpub\/ckl024","article-title":"Third Italian national survey on knowledge, attitudes, and sexual behaviour in relation to HIV\/AIDS risk and the role of health education campaigns","volume":"16","author":"C Signorelli","year":"2006","journal-title":"Eur J Public Health"},{"key":"ref30","article-title":"Sex in Sweden - On the Swedish Sexual Life","author":"B Lewin","year":"2000"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/imammb\/11.3.161","article-title":"Balancing sexual partnerships in an age and activity stratified model of HIV transmission in heterosexual populations","volume":"11","author":"GP Garnett","year":"1994","journal-title":"IMA J Math Appl Med Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4682-5-4","article-title":"Sampling and sensitivity analyses tools (SaSAT) for computational modelling","volume":"5","author":"A Hoare","year":"2008","journal-title":"Theor Biol Med Model"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"M Plummer","year":"2007","journal-title":"J Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"AC Rodr\u00edguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ijc.24752","article-title":"Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology","volume":"126","author":"D Maucort-Boulch","year":"2010","journal-title":"Int J Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/EDE.0b013e3181c1e70b","article-title":"Human papillomavirus infections among couples in new sexual relationships","volume":"21","author":"AN Burchell","year":"2010","journal-title":"Epidemiology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/infdis\/jir644","article-title":"Genital transmission of human papillomavirus in recently formed heterosexual couples","volume":"204","author":"AN Burchell","year":"2011","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ijc.26362","article-title":"Efficacy of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16\/18","volume":"131","author":"A Szarewski","year":"2012","journal-title":"Int J Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/bjc.2011.185","article-title":"End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age","volume":"105","author":"X Castellsagu\u00e9","year":"2011","journal-title":"Br J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/jnci\/djq384","article-title":"Epidemiological study of anti-HPV16\/18 seropositivity and subsequent risk of HPV16 and -18 infections","volume":"102","author":"M Safaeian","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1016\/j.vaccine.2012.04.087","article-title":"Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: a dynamic individual-based approach","volume":"30","author":"T Vanni","year":"2012","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1016\/j.vaccine.2009.09.125","article-title":"Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom","volume":"28","author":"YH Choi","year":"2010","journal-title":"Vaccine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1136\/sti.78.suppl_1.i14","article-title":"The geographical and temporal evolution of sexually transmitted disease epidemics","volume":"78","author":"GP Garnett","year":"2002","journal-title":"Sex Transm Infect"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"135ra67","DOI":"10.1126\/scitranslmed.3003815","article-title":"Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis","volume":"4","author":"R Sergeev","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref45","first-page":"39","article-title":"Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity","volume":"36","author":"G Ronco","year":"2012","journal-title":"Epidemiol Prev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/1055-9965.EPI-09-0983","article-title":"Concurrent Infection with Multiple Human Papillomavirus Types: Pooled Analysis of the IARC HPV Prevalence Surveys","volume":"19","author":"S Vaccarella","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.ejca.2011.10.010","article-title":"Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study","volume":"48","author":"F Carozzi","year":"2012","journal-title":"Eur J Cancer"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jir286","article-title":"Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica","volume":"204","author":"S Vaccarella","year":"2011","journal-title":"J Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1098\/rstb.1993.0143","article-title":"Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes","volume":"342","author":"GP Garnett","year":"1993","journal-title":"Philos Trans R Soc Lond B Biol Sci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0081171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:59:50Z","timestamp":1540339190000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0081171"}},"subtitle":[],"editor":[{"given":"Gerardo","family":"Chowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,29]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0081171","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,29]]}}}